Atlas Trials

Lorlatinib - PF-06463922

Clinical trial NCT03127618 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT03127618
Sponsor
Pfizer
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.